Q1 2024 J B Chemicals and Pharmaceuticals Ltd Earnings Call Transcript
Ladies and gentlemen, good day, and welcome to Q1 FY24 earnings conference call of JB Pharma. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. Jason D'Souza, Executive Vice President of JB Pharma. Thank you and over to you, sir.
' -
Thank you, Nirav. Welcome to the earnings call of JB Pharma. We have with us today, Nikhil Chopra, CEO and Whole Time Director; Kunal Khanna, President, Operations; and Lakshay Kataria, Chief Financial Officer at JB Chemicals and Pharmaceuticals Limited.
Before we begin, I would like to state that some of the statements in today's discussion may be forward-looking in nature and may involve certain risks and uncertainties. A detailed statement in this regard is available in the Q1 FY24 investor presentation that has been sent to you earlier.
I would like to hand over the floor to Mr. Nikhil Chopra to begin the proceedings of the call for his opening comments, after
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |